SAM
LAB icon

Smartleaf Asset Management’s Standard BioTools LAB Stock Holding History

Smartleaf Asset Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$727 Sell
789
-3,806
-83% -$4.61K ﹤0.01% 3169
2025
Q4 		$5.74K Buy
4,595
+413
+10% +$555 ﹤0.01% 2650
2025
Q3 		$5.31K Buy
4,182
+3,393
+430% +$4.45K ﹤0.01% 2360
2025
Q2 		$938 Sell
789
-2,526
-76% -$2.8K ﹤0.01% 2489
2025
Q1 		$3.78K Buy
3,315
+3,087
+1,354% +$4.33K ﹤0.01% 2278
2024
Q4 		$403 Buy
+228
New +$425 ﹤0.01% 2809

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Smartleaf Asset Management's LAB Position: Q1 2026 in Review

Smartleaf Asset Management reduced its Standard BioTools (LAB) stake by 83% in Q1 2026, selling an estimated $4.61K and leaving 789 shares worth $727. The position accounts for ﹤0.01% of the portfolio, ranked #3169.

Smartleaf Asset Management first reported a position in LAB in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.74K in Q4 2025. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Smartleaf Asset Management held 789 shares of Standard BioTools worth $727 as of Q1 2026.
  • Smartleaf Asset Management sold 3,806 Standard BioTools shares in Q1 2026, an estimated $4.61K.
  • Standard BioTools made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #3169 holding.
  • Smartleaf Asset Management first reported a position in Standard BioTools in Q4 2024 and has held it in 6 quarters since.
  • Smartleaf Asset Management's Standard BioTools position peaked at $5.74K in Q4 2025.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.